|Daily Range||$72.65 - $73.66|
|52-Week Range||$60.62 - $89.46|
|Dividend (Yield)||$0.00 (0.0%)|
|Average Daily Volume||1,310,600|
|Current FY EPS||$3.00|
How do you think EW
will perform against the market?
Top EW Bull/Bear Pitches
TrackRonBaron (< 20)
Submitted February 20, 2008
Ron Baron owns 5204400 shares of Edwards Lifesciences Corp.. As of September 30th, 2007 EW was up 33.87% over the last quarter, composed 1.27% of his portfolio, and he controlled 9.18% of the company.
socalsy (< 20)
Submitted May 6, 2008
Its recent runup makes it overvalued. It would have to grow earnings over 21% a year for the next 5 years to justify $55/share.
News & Commentary
Healthcare Information Services
Edwards Lifesciences Corp (EW) Description
A global provider of products and technologies designed to treat advanced cardiovascular disease. The Company focuses on specific cardiovascular opportunities including heart valve disease, peripheral vascular disease and critical care technologies. Website: http://www.edwards.com/